“…Thus, NIR irradiation played two roles: it was the source for photothermal conversion to ablate the cancer cells and the trigger for DOX release from MCNs. NIR-based photothermal therapy and DOX-based chemotherapy substantially enhanced the therapeutic efficiency, as demonstrated by the in vitro CCK-8 assay [52]. The combination of carbon and silica components could produce mesoporous composite materials with high photothermal conversion efficiency and controlled drug-releasing performance.…”
Section: Mcbs For Photothermal and Synergistic Therapymentioning
confidence: 95%
“…To further control DOX release, HA was included as a gatekeeper to seal DOX within the mesopores of MCNs with a redox-responsive disulfide bond [52]. Upon the addition of enzyme Hyal-1, HA was degraded into low-molecular-weight fragments, triggering DOX release.…”
Section: Science China Materialsmentioning
confidence: 99%
“…Similar to carbon nanotubes and graphene [68][69][70][71][72], MCNs show strong optical absorption in the NIR region (e.g., 808 nm), indicating potential utility as the photothermal agent for photothermal ablation of cancer cells because NIR light penetrates deeply into tissues and is harmless to normal tissues [52,53]. Xu et al [53] recently demonstrated that FA-targeted MCNs showed superior photothermal-conversion efficiency compared to graphene oxide and showed that NIR irradiation accelerated the release of pre-loaded anticancer drugs from MCNs.…”
Section: Mcbs For Photothermal and Synergistic Therapymentioning
confidence: 99%
“…Xu et al [53] recently demonstrated that FA-targeted MCNs showed superior photothermal-conversion efficiency compared to graphene oxide and showed that NIR irradiation accelerated the release of pre-loaded anticancer drugs from MCNs. In addition, HA-targeted MCNs (MCNs-HA) were designed for targeted photothermal ablation of tumor and synergistic on-demand drug release [52]. MCNs-HA targeted to CD44 overexpressed cell membranes and entered the cancer cells, and then DOX release was triggered and accelerated by NIR irradiation.…”
Section: Mcbs For Photothermal and Synergistic Therapymentioning
Nano-biotechnology provides highly efficient and versatile strategies to improve the diagnostic precision and therapeutic efficiency of serious diseases. The development of new biomaterial systems provides great opportunities for the successful clinical translation of nano-biotechnology for personalized biomedicine to benefit patients. As a new inorganic material system, mesoporous carbon biomaterials (
“…Thus, NIR irradiation played two roles: it was the source for photothermal conversion to ablate the cancer cells and the trigger for DOX release from MCNs. NIR-based photothermal therapy and DOX-based chemotherapy substantially enhanced the therapeutic efficiency, as demonstrated by the in vitro CCK-8 assay [52]. The combination of carbon and silica components could produce mesoporous composite materials with high photothermal conversion efficiency and controlled drug-releasing performance.…”
Section: Mcbs For Photothermal and Synergistic Therapymentioning
confidence: 95%
“…To further control DOX release, HA was included as a gatekeeper to seal DOX within the mesopores of MCNs with a redox-responsive disulfide bond [52]. Upon the addition of enzyme Hyal-1, HA was degraded into low-molecular-weight fragments, triggering DOX release.…”
Section: Science China Materialsmentioning
confidence: 99%
“…Similar to carbon nanotubes and graphene [68][69][70][71][72], MCNs show strong optical absorption in the NIR region (e.g., 808 nm), indicating potential utility as the photothermal agent for photothermal ablation of cancer cells because NIR light penetrates deeply into tissues and is harmless to normal tissues [52,53]. Xu et al [53] recently demonstrated that FA-targeted MCNs showed superior photothermal-conversion efficiency compared to graphene oxide and showed that NIR irradiation accelerated the release of pre-loaded anticancer drugs from MCNs.…”
Section: Mcbs For Photothermal and Synergistic Therapymentioning
confidence: 99%
“…Xu et al [53] recently demonstrated that FA-targeted MCNs showed superior photothermal-conversion efficiency compared to graphene oxide and showed that NIR irradiation accelerated the release of pre-loaded anticancer drugs from MCNs. In addition, HA-targeted MCNs (MCNs-HA) were designed for targeted photothermal ablation of tumor and synergistic on-demand drug release [52]. MCNs-HA targeted to CD44 overexpressed cell membranes and entered the cancer cells, and then DOX release was triggered and accelerated by NIR irradiation.…”
Section: Mcbs For Photothermal and Synergistic Therapymentioning
Nano-biotechnology provides highly efficient and versatile strategies to improve the diagnostic precision and therapeutic efficiency of serious diseases. The development of new biomaterial systems provides great opportunities for the successful clinical translation of nano-biotechnology for personalized biomedicine to benefit patients. As a new inorganic material system, mesoporous carbon biomaterials (
“…However, traditional hyperthermia is usually invasive, non-uniform, and the desired therapeutic efficacy without non-specific cell damage requires sophisticated temperature control [196]. Various nanomaterials with a highabsorption cross-section for converting an external energy source (e.g., magnetic field, light, and ultrasound) into heat have been developed for minimally invasive and uniform hyperthermia [197][198][199][200][201][202][203]. Particularly, gold and carbon nanomaterials whose hyperthermal effects are triggered upon irradiation by noninvasive, deep-penetrating nearinfrared light (NIR) have been widely explored as efficient agents for photothermal therapy [34][35][36]204].…”
Section: Combined Photothermal and Chemotherapymentioning
a b s t r a c t a r t i c l e i n f oThe dynamic and versatile nature of diseases such as cancer has been a pivotal challenge for developing efficient and safe therapies. Cancer treatments using a single therapeutic agent often result in limited clinical outcomes due to tumor heterogeneity and drug resistance. Combination therapies using multiple therapeutic modalities can synergistically elevate anti-cancer activity while lowering doses of each agent, hence, reducing side effects. Co-administration of multiple therapeutic agents requires a delivery platform that can normalize pharmacokinetics and pharmacodynamics of the agents, prolong circulation, selectively accumulate, specifically bind to the target, and enable controlled release in target site. Nanomaterials, such as polymeric nanoparticles, gold nanoparticles/cages/shells, and carbon nanomaterials, have the desired properties, and they can mediate therapeutic effects different from those generated by small molecule drugs (e.g., gene therapy, photothermal therapy, photodynamic therapy, and radiotherapy). This review aims to provide an overview of developing multi-modal therapies using nanomaterials ("combo" nanomedicine) along with the rationale, up-to-date progress, further considerations, and the crucial roles of interdisciplinary approaches.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.